HEPION PHARMACEUTICA (HEPA) insider trading activity (SEC Form 4). Over the trailing 90 days, HEPA insiders filed 5 purchases totalling $825K and 0 sales totalling $0 — net BUYING of $825K. Most recent filing: Aug 12, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Stetz Gary S. II | Dir | P Purchase | — | $0.05 | $25K | filing |
| Aug 12, 2026 | Stetz Gary S. | Interim CEO | P Purchase | — | $0.05 | $100K | filing |
| Aug 12, 2026 | Purcell Michael J. | Dir | P Purchase | — | $0.05 | $100K | filing |
| Aug 12, 2026 | Appajosyula Sireesh | COO | P Purchase | — | $0.05 | $100K | filing |
| Aug 12, 2026 | Lopriore Vincent S | Exec COB | P Purchase | — | $0.05 | $500K | filing |